SMTL ID : 3wyk.1 (2 other biounits)

Crystal structure of the catalytic domain of PDE10A complexed with 3-(1-phenyl-1H-pyrazol-5-yl)-1-(3-(trifluoromethyl)phenyl)pyridazin-4(1H)-one

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

homo-dimer

Ligands

2 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 3 residues within 4Å: Chain A: D.113, E.141 Ligands: ZN.2 6 PLIP interactions: 1 interactions with chain A, 5 Ligand-Water interactions Metal complexes: A:D.113, H2O.2, H2O.2, H2O.3, H2O.3, H2O.3 MG.4: 4 residues within 4Å: Chain B: H.112, D.113, E.141 Ligands: ZN.5 6 PLIP interactions: 1 interactions with chain B, 5 Ligand-Water interactions Metal complexes: B:D.113, H2O.4, H2O.4, H2O.6, H2O.6, H2O.6

2 x ZN: ZINC ION(Non-covalent)

ZN.2: 5 residues within 4Å: Chain A: H.78, H.112, D.113, D.223 Ligands: MG.1 6 PLIP interactions: 4 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:H.78, A:H.112, A:D.113, A:D.223, H2O.2, H2O.3 ZN.5: 5 residues within 4Å: Chain B: H.78, H.112, D.113, D.223 Ligands: MG.4 6 PLIP interactions: 4 interactions with chain B, 2 Ligand-Water interactions Metal complexes: B:H.78, B:H.112, B:D.113, B:D.223, H2O.6, H2O.6

2 x 3KG: 3-(1-phenyl-1H-pyrazol-5-yl)-1-[3-(trifluoromethyl)phenyl]pyridazin-4(1H)-one(Non-covalent)

3KG.3: 11 residues within 4Å: Chain A: Y.73, H.74, L.184, L.224, V.227, I.241, Y.242, F.245, M.262, Q.275, F.278 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:Y.73, A:L.184, A:L.224, A:V.227, A:I.241, A:I.241, A:F.278, A:F.278 Hydrogen bonds: A:Y.73, A:Q.275 pi-Stacking: A:F.245, A:F.278 3KG.6: 11 residues within 4Å: Chain B: Y.73, H.74, L.184, L.224, V.227, I.241, Y.242, F.245, M.262, Q.275, F.278 11 PLIP interactions: 11 interactions with chain B Hydrophobic interactions: B:Y.73, B:L.184, B:L.224, B:V.227, B:I.241, B:I.241, B:F.278, B:F.278 Hydrogen bonds: B:Y.73, B:Q.275 pi-Stacking: B:F.278

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kunitomo, J. et al., Discovery of 1-[2-fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one (TAK-063), a highly potent, selective, and orally active phosphodiesterase 10A (PDE10A) inhibitor. J.Med.Chem. (2014)

Release Date

2014-11-19

Peptides

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A

Related Entries With Identical Sequence